Orchestra BioMed Expands Global Patent Portfolio for Hypertension Therapy
NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) has announced a significant expansion of its global patent portfolio, signaling a major stride in the development of atrioventricular interval …
Orchestra BioMed Expands Global Patent Portfolio for Hypertension Therapy Read More